Clinical Trials Directory

Trials / Unknown

UnknownNCT04531644

Double Stimulation in Women With Low Prognosis in ART

Impact of Double Stimulation (DuoStim) in Women Affected by Low Prognosis to Assisted Reproductive Technologies

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Tu Du Hospital · Other Government
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The main objective of this study is to compare the cumulative ongoing pregnancy rates of two different IVF protocols in women candidate for ART characterized by low prognosis.

Detailed description

The patients will be allocated into two groups: control and study group \_ In study group, patients will be treated by DuoStim protocol: The first phase of ovarian stimulation is started on the second day or third day of period. GnRH agonist will be used to trigger when at least two follicles ≥ 17 mm. Approximately 36 hours later, oocytes will be retrieved vaginally under ultrasound monitoring and ICSI will be performed. Five days later after oocyte retrieval, the second stimulation will be started. All embryos will be cryopreserved. \_ In control group, patients will be treated with antagonist protocol: The cycle of ovarian stimulation is started on the second day or third day of period. hCG will be used to trigger when at least two follicles ≥ 17 mm. Approximately 36 hours later, oocytes will be retrieved vaginally under ultrasound monitoring and ICSI will be performed. If serum progesterone on the day of trigger ≥ 1.5 ng/ml, all embryos will be cryostored; otherwise, fresh embryos will be transferred.

Conditions

Interventions

TypeNameDescription
PROCEDUREdouble stimulationthe patients will be treated with two consecutive ovarian stimulations in one cycle
PROCEDUREconventional ovarian stimulationthe patients will be treated with one conventional ovarian stimulation in one cycle

Timeline

Start date
2020-05-14
Primary completion
2024-02-28
Completion
2024-03-30
First posted
2020-08-28
Last updated
2023-12-06

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT04531644. Inclusion in this directory is not an endorsement.